Zobrazeno 1 - 10
of 6 642
pro vyhledávání: '"Left Ventricular Ejection Fraction"'
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 4360-4370 (2024)
Abstract Aims Epidemiological and outcome studies on patients in Japan with heart failure (HF) categorized by left ventricular ejection fraction (LVEF) are currently limited. The aim of this non‐interventional database study was to provide further
Externí odkaz:
https://doaj.org/article/bae00724c6114630825fecee5f5b6aaa
Autor:
Ana Viana-Tejedor, Carlos Ferrera, Rodrigo Estévez-Loureiro, Manuel Barreiro-Pérez, Pilar Jiménez Quevedo, Luis Nombela-Franco, Pablo Jorge-Pérez, Isaac Pascual, Amparo Martínez Monzonís, Ana Belén Cid Álvarez
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 6, Iss 4, Pp 313-320 (2024)
ABSTRACT The approach to patients with acute mitral regurgitation poses a therapeutic challenge. These patients have a very high morbidity and mortality rate, thus requiring a multidisciplinary approach. This document presents the position of 3 assoc
Externí odkaz:
https://doaj.org/article/6072e910bf804da58aa3f60415ca38ea
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Heart failure with improved ejection fraction (HFimpEF) has been regarded as a new heart failure (HF) type in 2022. However, studies on the impact of left ventricular ejection fraction (LVEF) trajectories on the prognosis of patie
Externí odkaz:
https://doaj.org/article/5e0a3631feea4d579e98eb14a528ab05
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 10, Pp 4145-4148 (2024)
SGLT-2 inhibitors are a class of antidiabetic drugs with additional cardiovascular benefits. Though initially developed for glycemic control, subsequent studies in the heart failure (HF) population also demonstrated positive outcomes. Currently, they
Externí odkaz:
https://doaj.org/article/dc151f1467a548058d20433a5e6784e7
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Left ventricular ejection fraction (LVEF) is the most ubiquitous parameter in cardiac imaging examinations, we aimed to investigate the associations between subtle changes of LVEF and risk of common cardiovascular diseases. This is a prospec
Externí odkaz:
https://doaj.org/article/8e6091e1bdae4e639fe83f355b42616c
Autor:
Merab A. Shariya, Dmitry V. Ustyuzhanin, Igor V. Zhirov, Yulia F. Osmolovskaya, Sergey N. Tereshchenko
Publikováno v:
Терапевтический архив, Vol 96, Iss 09, Pp 909-913 (2024)
Cognitive impairment is a very common comorbidity in patients with heart failure (HF). Patients with HF show signs of memory decline, difficulty concentrating, and attention deficits. Cognitive dysfunction in HF is associated with a poor prognosis. H
Externí odkaz:
https://doaj.org/article/a55c5cb2fcef4a17bbc62fa333fd412e
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Background While trastuzumab has been shown to improve disease-free and overall survival in patients with HER2-positive breast cancer, it may also cause trastuzumab-induced cardiotoxicity (TIC). Although racial and ethnic minorities are at h
Externí odkaz:
https://doaj.org/article/096b2f47c44b4dfa86207b9dad971720
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 20, Pp 711-718 (2024)
Aiwen Wang,1,2 Zhuo Yuan,3 Xingpeng Bu,1 Shuzhen Bi,2 Yadong Cheng,4 Huanzhen Chen5 1First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, 030000, People’s Republic of China; 2Department of Emergency, Changzhi People’s Hospi
Externí odkaz:
https://doaj.org/article/4ecb02e7fb3f4e99a9928ead26301c26
Autor:
Masamichi Yano, Yasuyuki Egami, Shodai Kawanami, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masami Nishino
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3368-3377 (2024)
Abstract Aims Catheter ablation (CA) of atrial fibrillation (AF) improves left ventricular ejection fraction (LVEF) in patients with heart failure with reduced ejection fraction (HFrEF). The impact of ST‐segment depression before CA on LVEF recover
Externí odkaz:
https://doaj.org/article/d5b952bf928848e9bf48c7518f632630
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3085-3094 (2024)
Abstract Aims Sudden cardiac death (SCD) is a common mode of death in patients with congestive heart failure (CHF). Implantable cardioverter defibrillator (ICD) implantation is established treatment for SCD prevention, but current eligibility criteri
Externí odkaz:
https://doaj.org/article/eea0c55905cf4dfc912d46fea7c75bee